L&K Biomed

156100 · KOSDAQ · ₩156100 · 엘앤케이바이오

₩6,270▼ ₩910 (12.67%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩39B₩36B₩30B₩20B₩15B
Cost of sales₩6.8B₩5.8B₩4.1B₩4.9B₩7.9B
Gross profit₩32B₩30B₩26B₩15B₩7.5B
Operating income₩715M₩3.1B₩2B−₩13B−₩15B
Net income−₩17B₩9.2B−₩5.2B−₩16B−₩14B
Net income to shareholders−₩16B₩9.7B−₩1.9B−₩14B−₩9.7B

Balance sheet

20252024202320222021
Total assets₩83B₩83B₩63B₩53B₩59B
Current assets₩61B₩64B₩44B₩36B₩38B
Cash and equivalents₩3.2B₩3.8B₩5B₩7.4B₩16B
Total liabilities₩45B₩47B₩32B₩42B₩34B
Current liabilities₩38B₩39B₩23B₩38B₩13B
Borrowings₩16B₩22B₩11B₩23B₩20B
Total equity₩39B₩36B₩31B₩11B₩25B
Shareholders' equity₩45B₩42B₩35B₩12B₩24B

Cash flow

20252024202320222021
Cash from operations−₩14B−₩7.4B−₩1.4B−₩6.9B−₩11B
Capital spending₩3B₩585M₩2B−₩197M−₩99M
Free cash flow−₩17B−₩8B−₩3.4B−₩7.1B−₩11B

Consolidated where available. Amounts in won.

Also known as: L&K Biomed / 엘앤케이바이오 / 156100 / KRX:156100

Source: KRX statistical information